Haut.AI's Clinical Studies Software automates skin biomarker measurement through standardized image capture and AI analysis, reducing clinical trial setup from 8-16 weeks to 2-3 days. The platform quantifies 48 validated skin endpoints with high repeatability (ICC 0.97-0.98) and demonstrates concordance with expert assessment whether captured on medical or consumer devices.
Key Points
- Accelerates clinical trial initiation from weeks to days through workflow automation
- Measures 48 validated skin biomarkers including wrinkles, pigmentation, texture, acne
- Achieves 0.97-0.98 intraclass correlation across endpoints with consumer-grade imaging
Longevity Analysis
The ability to measure skin structural changes with precision and speed reframes how we assess aging trajectories and intervention efficacy. Skin serves as an accessible biomarker window into systemic processes—collagen turnover, oxidative stress, regenerative capacity, and inflammatory state all manifest at the dermal level. Standardizing these measurements at scale enables researchers and practitioners to correlate topical or systemic interventions with objective, reproducible tissue responses, moving beyond subjective assessment or invasive biopsy. This infrastructure supports faster validation cycles for compounds and protocols that target the regenerative and stress-response systems.
Original published by LT Wire.